Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $1.27M | $-69.69M | $-1.83 |
| 2025 | $486.0K | $-51.42M | $-1.67 |
| 2024 | $1.06M | $-29.36M | $-1.52 |
| 2023 | $-227.0K | $-59.25M | $-8.51 |
| 2022 | $1.11M | $-47.76M | $-7.38 |
Social Signal Score
Earnings
Thu, Nov 12(in 3 months)
Consensus estimate $-0.38 per share
Typical surprise +11.8% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$-0.30 vs $-0.36beat
- Mon, Jun 15$-0.37 vs $-0.42beat
- Thu, Feb 12$-0.45 vs $-0.51beat
- Thu, Nov 13$-0.54 vs $-0.51miss
- Thu, Aug 7$-0.47 vs $-0.47beat
- Tue, Jun 17$-0.43 vs $-0.52beat
Estimates and results for VTGN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
VTGNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·1d ago·Neutral
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update Exploratory analyses of patients with very severe social anxiety disorder demonstrated nominally statistically significant improvement in recently reported clinical studies
View source ↗